4'-Chloro-4-nitro-biphenyl-3-carbaldehyde | 515879-11-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4'-Chloro-4-nitro-biphenyl-3-carbaldehyde
• 英文别名: 4'-Chloro-4-nitrobiphenyl-3-carbaldehyde；5-(4-chlorophenyl)-2-nitrobenzaldehyde
• CAS: 515879-11-5
• 化学式: C₁₃H₈ClNO₃
• 分子量: 261.664
• InChiKey: KATBBLUIBLHDKC-UHFFFAOYSA-N

物化性质

• 沸点：
  436.8±40.0 °C(Predicted)
• 密度：
  1.375±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  62.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4'-Chloro-4-nitro-biphenyl-3-carbaldehyde 在 palladium on activated charcoal sodium perborate 、 草酰氯 、 DIEA resin 、 氢气 、 溶剂黄146 、 N,N-二甲基甲酰胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 16.0h， 生成 4-Amino-4'-chloro-biphenyl-3-carboxylic acid [3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide
  参考文献：
  名称：

  Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849

  摘要：

  A strategy of systematically targeting more rigid analogues of the known MCH R1 receptor antagonist, SB-568849, serendipitously uncovered a binding mode accessible to N-aryl-phthalimide ligands. Optimisation to improve the stability of this compound class led to the discovery of novel N-aryl-quinazolinones, benzotriazinones and thienopyrimidinones as selective ligands with good,affinity for human melanin-concentrating hormone receptor 1. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.06.061
• 作为产物：
  描述：

  4'-Chloro-3-(1,1-dichloromethyl)-4-nitrobiphenyl 在 水 、 silver trifluoromethanesulfonate 作用下， 以 乙腈 为溶剂， 生成 4'-Chloro-4-nitro-biphenyl-3-carbaldehyde
  参考文献：
  名称：

  Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849

  摘要：

  A strategy of systematically targeting more rigid analogues of the known MCH R1 receptor antagonist, SB-568849, serendipitously uncovered a binding mode accessible to N-aryl-phthalimide ligands. Optimisation to improve the stability of this compound class led to the discovery of novel N-aryl-quinazolinones, benzotriazinones and thienopyrimidinones as selective ligands with good,affinity for human melanin-concentrating hormone receptor 1. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.06.061

文献信息

• Pd‐Catalyzed Tandem Coupling Reaction of 2‐ <i>gem</i> ‐Dibromovinylanilines and <i>N</i> ‐Tosylhydrazones to Construct 2‐(1‐phenylvinyl)‐indoles
  作者：Jian Song、Xiaochen Chi、Long Meng、Pingping Zhao、Fenggang Sun、Daopeng Zhang、Luyang Jiao、Qing Liu、Yunhui Dong、Hui Liu

  DOI：10.1002/adsc.201900230

  日期：2019.8.5

  A novel palladium(0)‐catalyzed intermolecular coupling reaction of 2‐gem‐dibromovinylanilines and N‐tosylhydrazones was reported to construct 2‐(1‐phenylvinyl)‐indoles efficiently. The indole bearing 1, 1‐disubstituted alkenes were obtained in one step with short reaction time, in high yields and broad substrate scope. The formed indole derivates could be easily transformed into much more valuable

  一种新颖的钯（0）催化的分子间2-偶联反应宝石-dibromovinylanilines和Ñ报道-tosylhydrazones构建2-（1-苯基乙烯基）有效地-indoles。一步法，反应时间短，产率高，底物范围广，可得到带有吲哚的1，1-二取代烯烃。形成的吲哚衍生物很容易转化为更有价值的分子。
• Lactam derivatives as antagonists for human 11cby receptors
  申请人：Armstrong Anne Sula

  公开号：US20050059651A1

  公开（公告）日：2005-03-17

  The invention provides compounds of formula (I) a salt, or solvate thereof.

  该发明提供了式(I)的化合物，其盐或溶剂。
• Novel Lactam Derivatives
  申请人：Armstrong Anne Sula

  公开号：US20060287321A1

  公开（公告）日：2006-12-21

  The invention thus provides compounds of formula (I) a salt, or solvate thereof.

  该发明因此提供了公式(I)的化合物，其盐或溶剂。
• Intramolecular CH‐Hydrogen Bonding During the Dissociation of the Oxaphosphetane Intermediate Facilitates <i>Z/E</i>‐Selectivity in Wittig Olefination
  作者：Kukkamudi Sreenivas、Chintada Nageswara Rao、Faiz Ahmed Khan

  DOI：10.1002/open.202300171

  日期：2024.3

  The Z-selective synthesis of novel nitrostilbenes has been reported. An intrinsic role of intramolecular hydrogen bonding during the dissociation of OPA-intermediate is critical for the stereoselective Wittig olefination. DFT calculations and X-ray measured intramolecular CH hydrogen bonding distances strongly support the observed phenomenon. Further, the current methodology has been utilized to synthesize

  新型硝基芪的Z选择性合成已有报道。 OPA-中间体解离过程中分子内氢键的内在作用对于立体选择性 Wittig 烯化至关重要。 DFT 计算和 X 射线测量的分子内 CH 氢键距离有力地支持了观察到的现象。此外，目前的方法已用于合成具有药用潜力的水杨酸甲酯基2-芳基吲哚衍生物。
• AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1849465A1

  公开（公告）日：2007-10-31

  The present invention provides a GPR receptor function regulator comprising the compound represented by the formula: [wherein ring A is an optionally substituted isocyclic or heterocyclic ring, P is a bond or spacer, ring D is an optionally substituted monocyclic aromatic ring which may be condensed with a 5-to 7-membered ring, V is a bond or the group represented by the formula -CR14=CR15 - or - N=CR16- (wherein R14, R15 and R16 each represents a hydrogen atom or optionally substituted hydrocarbon group), Q is a bond or spacer, and W is a carboxyl or a group biologically equivalent to a carboxyl] or its salt or a prodrug thereof

  本发明提供了一种 GPR 受体功能调节剂，包括由式表示的化合物： [其中环A是任选取代的异环或杂环，P是键或间隔物，环D是任选取代的单环芳香环，可与5-7元环缩合，V是键或由式-CR14＝CR15-或-N＝CR16-代表的基团（其中R14、R15 和 R16 各代表一个氢原子或任选取代的烃基），Q 是键或间隔物，W 是羧基或生物等价于羧基的基团]或其盐或其原药